MTANZ

Select Relevant Account

Select yourself to see only your informmation.
Select an organisation to manage it as well.

Login





Forgot password?
Create an Account

In The News

News NZ health sector learning to embrace the tech world
02 Aug 2017
News Kiwi doctors swapping stethoscopes for iPads
07 Jul 2017
News World experts in wearable tech gather to inspire NZers
14 Jun 2017
News Investigator's report into Auckland dental contamination scare released
12 Jun 2017
News World’s First Medical Device Initiative to Save Sight
30 May 2017
News Diabetes scanning technology replaces pricking
25 May 2017
News Rex Bionics shareholders back lifeline deal
25 May 2017
News Mike Daniell joins board of Australasia’s largest life science venture capital fund.
17 May 2017
News TGA releases new clinical guidelines for Medical Devices and IVDs
31 Mar 2017
News Call from Health Minister for clinicians to share ‘disruptive’ ideas
27 Mar 2017
News EpiPen adrenaline auto-injectors recalled in NZ
23 Mar 2017
News Surgical Mesh - Media Release MTANZ
22 Mar 2017
News New Role for Dr Diana Siew to develop International Partnerhips
21 Mar 2017
News Samsung testing new heart monitor at Middlemore Hospital
03 Mar 2017
News MTAA appoints Ian Burgess as CEO
21 Dec 2016
News Molteno Ophthalmic Ltd changes lives
23 Jul 2016
News Pacific Edge and MKM Health win NZ Healthcare Awards
22 Jun 2016
News NZ Health Technology Review
22 Jun 2016
News Smart technology will transform NZ healthcare - Media Release MTANZ
15 Jun 2016
News New surgical scholarship program by RACS and Johnson & Johnson Medical
10 May 2016
PagePage123
 
Surgical Design Studio Granted Breakthrough Device Designation by US FDA 20 Jun 2019


Surgical Design Studio (SDS), a provider of innovative products for gastrointestinal diseases, today announces its medical devices have been granted Breakthrough Device designation by the United States Food and Drug Administration (FDA).
This appears to be the first time a New Zealand medical device company has been granted entry into the FDA’s Breakthrough Devices regulatory pathway, which is designed to help patients gain more timely access to medical devices that provide a more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
Garth Sutherland, CEO of Surgical Design Studio said “this designation validates the importance of the work SDS is doing for patients with intestinal diseases such as bowel cancer and inflammatory bowel disease, and provides us with an opportunity to significantly reduce our time to market for the US.”

TOP

©copyright Medical Technology Association of New Zealand, all rights reserved. Privacy Policy and Disclaimer.

Powered by streamSWEET CMS